# Evaluation of Innovative Tools in Development of Antibiotics

> **NCT03177720** · PHASE1 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 10 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Ciprofloxacin
- **DRUG:** Imipenem

## Key facts

- **NCT ID:** NCT03177720
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-29
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03177720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03177720, "Evaluation of Innovative Tools in Development of Antibiotics". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03177720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*